Tumour mutation status and melanoma recurrence following a negative sentinel lymph node biopsy

BACKGROUND: A proportion of patients develop recurrence following a tumour-negative sentinel lymph node biopsy (SLNB). This study aimed to explore whether melanoma patients with BRAF or NRAS mutant tumours have an increased risk of developing disease recurrence following a negative SLNB compared to...

Descripción completa

Detalles Bibliográficos
Autores principales: Adler, Nikki R., Wolfe, Rory, McArthur, Grant A., Kelly, John W., Haydon, Andrew, McLean, Catriona A., Mar, Victoria J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959932/
https://www.ncbi.nlm.nih.gov/pubmed/29755118
http://dx.doi.org/10.1038/s41416-018-0088-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959932/
https://www.ncbi.nlm.nih.gov/pubmed/29755118
http://dx.doi.org/10.1038/s41416-018-0088-8

Ejemplares similares